People: Novogen Ltd (NVGN.O)

NVGN.O on Consolidated Issue listed on NASDAQ Capital Market

2.45USD
22 Dec 2014
Price Change (% chg)

$-0.13 (-5.04%)
Prev Close
$2.58
Open
$2.63
Day's High
$2.64
Day's Low
$2.40
Volume
429,376
Avg. Vol
439,906
52-wk High
$5.97
52-wk Low
$1.51

Search Stocks

Hinze, Mark 

Brief Biography

Mr. Mark G. Hinze, CPA, is Chief Financial Officer of Novogen Ltd since June 18, 2010. He joined the Novogen Group in 1999 and previously held the position of the Group’s Financial Controller. Mr. Hinze holds a Bachelors Degree in Economics from Macquarie University and is a CPA. Mr. Hinze has over 18 years experience in accounting and finance. Prior to joining Novogen Mr. Hinze worked as the Finance and Administration Manager of Alpha Healthcare’s Pathology division. Mr. Hinze was also the Finance Manager for Diagnostic Pathology prior to its sale to Alpha Healthcare.

Basic Compensation

Total Annual Compensation, AUD Long-Term Incentive Plans, AUD All Other, AUD Fiscal Year Total, AUD
286,279 -- 39,624 325,903

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Graham Kelly

402,148

Mark Hinze

325,903

Daniel Gold

814,617

Andrew Heaton

--

David Brown

--

Craig Kearney

480,977
As Of 29 Jun 2013
Search Stocks